Bleeding Risk, Management and Outcome in Patients Receiving Non-VKA Oral Anticoagulants (NOACs) (vol 15, pg 235, 2015)

被引：0
|
作者：
Werth, Sebastian [1 ,2 ]
Breslin, Tomas [3 ]
NiAinle, Fionnuala [4 ]
Beyer-Westendorf, Jan [1 ,2 ]
机构：
[1] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Div Angiol, Ctr Vasc Med, D-01307 Dresden, Germany
[2] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dept Med 3, D-01307 Dresden, Germany
[3] Mater Misericordiae Univ Hosp, Dept Emergency Med, Dublin 7, Ireland
[4] Mater Misericordiae Univ Hosp, Dept Haematol, Dublin 7, Ireland
来源：
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS | 2015年 / 15卷 / 06期
关键词：
D O I：
10.1007/s40256-015-0151-2
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：451 / 452
页数：2
相关论文
共 50 条
  • [1] Bleeding Risk, Management and Outcome in Patients Receiving Non-VKA Oral Anticoagulants (NOACs)
    Sebastian Werth
    Tomás Breslin
    Fionnuala NiAinle
    Jan Beyer-Westendorf
    American Journal of Cardiovascular Drugs, 2015, 15 : 235 - 242
  • [2] Bleeding Risk, Management and Outcome in Patients Receiving Non-VKA Oral Anticoagulants (NOACs)
    Werth, Sebastian
    Breslin, Tomas
    NiAinle, Fionnuala
    Beyer-Westendorf, Jan
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2015, 15 (04) : 235 - 242
  • [3] Erratum to: Bleeding Risk, Management and Outcome in Patients Receiving Non-VKA Oral Anticoagulants (NOACs)
    Sebastian Werth
    Tomás Breslin
    Fionnuala NiAinle
    Jan Beyer-Westendorf
    American Journal of Cardiovascular Drugs, 2015, 15 : 451 - 452
  • [4] Impact of non-VKA oral anticoagulants on AF ablation outcome
    Zweiker, D.
    Manninger, M.
    Ebner, J.
    Sieghartsleitner, R.
    Ohnewein, B.
    Bisping, E.
    Lercher, P.
    Prenner, G.
    Riedlbauer, R.
    Brussee, H.
    Scherr, D.
    WIENER KLINISCHE WOCHENSCHRIFT, 2017, 129 : S41 - S41
  • [5] Are non-VKA oral anticoagulants (NOACS) plasma concentrations associated with the risk of postoperative bleeding? Preliminary results from the real life cohort
    Olivera, P. E.
    Pons, V
    Cortina, V
    Lopez-Andreoni, L.
    Artaza, G.
    Marin, A.
    Bosch, F.
    Santamaria, A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 899 - 899
  • [6] Intravenous thrombolysis for stroke in patients taking non-VKA oral anticoagulants: an update
    Cappellari, Manuel
    Bovi, Paolo
    THROMBOSIS AND HAEMOSTASIS, 2015, 114 (02) : 440 - 444
  • [7] Clinical Events Preceding Changes During Treatment With Non-VKA Oral Anticoagulants In Patients With Atrial Fibrillation
    Hellfritzsch, Maja
    Grove, Erik L.
    Husted, Steen E.
    Rasmussen, Lotte
    Poulsen, Birgitte K.
    Johnsen, Soren P.
    Hallas, Jesper
    Pottegard, Anton
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 : 499 - 499
  • [8] Localization, Management, Resource Consumption and Outcome of Major Gastrointestinal Bleeding in Patients with Direct Oral Anticoagulants, Vka and Antiplatelet Therapy
    Pannach, Sven
    Goetze, Julia
    Tittl, Luise
    Schreier, Thomas
    Marten, Sandra
    Hampe, Jochen
    Beyer-Westendorf, Jan
    BLOOD, 2016, 128 (22)
  • [9] Practical management of bleeding in patients receiving non-vitamin K antagonist oral anticoagulants
    Weitz, Jeffrey I.
    Pollack, Charles V., Jr.
    THROMBOSIS AND HAEMOSTASIS, 2015, 114 (06) : 1113 - 1126
  • [10] Treatment of patients with acute deep vein thrombosis and/or pulmonary embolism: Efficacy and safety of non-VKA oral anticoagulants in selected populations
    Prandoni, Paolo
    THROMBOSIS RESEARCH, 2014, 134 (02) : 227 - 233
12345